Linlithgow and East Falkirk MP Martyn Day supports cutting-edge medical technology

Linlithgow and East Falkirk MP Martyn Day met with Animal Free Research UK in Parliament to help showcase cutting-edge medical technology.

By Kevin Quinn
Thursday, 31st March 2022, 6:00 am
Martyn Day is pictured holding an example of a 3D organ on a chip, a cutting edge new approach method used in medical research. He is pictured next to CEO of Animal Free Research UK Carla Owen (left) and Queen Mary University London cancer research scientist, Dr Adrian Biddle. (Photo Credit AFRUK/Andrew Parsons).
Martyn Day is pictured holding an example of a 3D organ on a chip, a cutting edge new approach method used in medical research. He is pictured next to CEO of Animal Free Research UK Carla Owen (left) and Queen Mary University London cancer research scientist, Dr Adrian Biddle. (Photo Credit AFRUK/Andrew Parsons).

The event at Portcullis House in Westminster included Animal Free Research UK-funded scientist Dr Adrian Biddle and early career researcher Alice Scemama from Queen Mary University London, who demonstrated how New Approach Methodologies - known as NAMs - like organ on a chip are greatly improving new drug discovery processes.

Martyn Day MP said: “Drug development is notoriously slow and expensive – it can take up to 10 years and cost more than £1 billion to bring a new compound from the lab to market. A major cause of this inefficiency is the traditional reliance on testing drugs in animals before they are tested in humans."

He added: “Animals often do not accurately reflect human physiology, meaning that drugs which appear to be safe and effective in animals frequently turn out to be harmful or ineffective in humans. This mismatch in biology causes many ineffective or toxic drugs to advance through clinical trials at great expense, while potentially effective compounds never make it to market.

Sign up to our daily The Falkirk Herald Today newsletter

“As I and my Parliamentary colleagues learnt, there are better ways to model human biology and diseases, and these give the accurate data needed to accelerate the development of new drugs and personalised medicine.”

Animal Free Research UK works to highlight the need for a central role for human relevant science in the country’s post-Covid research and innovation strategy, and recommends the creation of a dedicated ministerial-level post to ‘lead an ambitious and detailed programme of work’ cutting across Government to drive the UK’s transition to human relevant science.

Carla Owen, CEO of Animal Free Research UK, said: “MPs have today seen first-hand how modern medical research methods are transforming our quest for better medicines and health – and why Britain has good reason to be proud of being a centre of excellence for science.

“They also learned how genetics and physiology between humans and animals greatly differ, and why we must not be left behind by relying on outdated animal experiments if we are to secure our international reputation as a science superpower.  

“We must embrace the high-tech alternatives to animal testing. Government must provide supportive infrastructure, funding, education and training, and regulations that enable human relevant research.  Because accelerating human relevant life sciences is good for human health, good for animals and good for the economy.”